Thetis Pharmaceuticals to Present at the World Orphan Drug Congress on TP-252, an Investigational Drug for Familial Adenomatous ...
SOUTHPORT, CT - (NewMediaWire) - April 14, 2016 - Thetis Pharmaceuticals LLC ("Thetis"), a privately-held biopharmaceutical company, today announced that Frank C. Sciavolino, Ph.D., Chief Scientific Officer, will present an overview of TP-252, …